Publications
353
Citations
4,721
Est. group size
~1
Recurring co-author estimate
Active years
31
Publishing since 1996
D. Wade Clapp studies neurofibromatosis (a group of genetic conditions that cause tumors to grow on nerves) and related nerve tumors such as schwannomas and neurofibromas. The work spans laboratory research into how these tumors develop from nerve-supporting cells and their surrounding tissue environment, as well as clinical trials testing drug therapies like bevacizumab in patients. Much of the research is conducted through multicenter clinical trial consortia and involves both children and adults.
After several years of modest output, publication activity rose sharply from 2023 onward, indicating strongly growing recent activity.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104
Journal of Neuro-Oncology · 2025
- Unlocking Brigatinib’s Potential: A Remarkable Case of Drug Repurposing in NF2-SWN
Pharmaceutical science. · 2024
- Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with <i>NF2</i>-related schwannomatosis and progressive vestibular schwannoma
Neuro-Oncology · 2023
- A Flattening of the Curve: The Challenge of Disparate Growth Rates in the Pediatric Subspecialties
The Journal of Pediatrics · 2023
- Addressing Gaps in Pediatric Scientist Development: The Department Chair View of 2 AMSPDC-Sponsored Programs
The Journal of Pediatrics · 2020
- Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma
Journal of Clinical Oncology · 2019
- Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1
Journal of Clinical Oncology · 2019
- Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis
Journal of Clinical Investigation · 2018
- Hospitalist Medicine—Chairs' Perspective of Specialty Status and Training Requirements
The Journal of Pediatrics · 2018
- NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY
Neuro-Oncology · 2018
- Abstract IA24: Identification of therapies for plexiform neurofibromas, a precursor of malignant peripheral nerve sheath tumors
Clinical Cancer Research · 2018
- Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis
2018
- The importance of nerve microenvironment for schwannoma development
Acta Neuropathologica · 2016
- Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor <i>Nf1</i> gene loss to promote malignant peripheral nerve sheath tumor formation
Oncotarget · 2016
- Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation
Digital Commons@Becker (Washington University School of Medicine) · 2016
- Clinical Cancer Research×5
- PMC×4
- Human Molecular Genetics×3
- Neuro-Oncology×3
- The Journal of Pediatrics×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile